Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
Open accessThe DOI matches its Crossref record; 48 of the 50 references it cites were found in a registry or an index.
Abstract
Bacteria can be genetically engineered to kill specific pathogens or inhibit their virulence. We previously developed a synthetic genetic system that allows a laboratory strain of Escherichia coli to sense and kill Pseudomonas aeruginosa in vitro . Here, we generate a modified version of the system, including a gene encoding an anti-biofilm enzyme, and use the probiotic strain Escherichia coli Nissle 1917 as host. The engineered probiotic shows in vivo prophylactic and therapeutic activity against P. aeruginosa during gut infection in two animal models ( Caenorhabditis elegans and mice). These findings support the further development of engineered microorganisms with potential prophylactic and therapeutic activities against gut infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“For example, Hwang et. al. demonstrated that the EcN-based gastrointestinal delivery of anti-biofilm enzyme, dispersin B (DspB), resulted in a reduction of pre-colonized P. aeruginosa abundance in both nematode and murine models29.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [29]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Regulating effector expression in response to bacterial quorum sensing molecules29, pH30, specific carbon sources31–33, temperature34, or combinations of these signals may allow for exquisitely tuned effector functions in various intestinal microenvironments7.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Interdependence of Cell Growth and Gene Expression: Origins and Consequences
Scott, M., Gunderson, C. W., Mateescu, E. M., Zhang, Z., & Hwa, T. (2010) · Science · doi:10.1126/science.1192588 · Cited by 1,470
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Tan, M.-W., Mahajan-Miklos, S., & Ausubel, F. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.715 · Cited by 1,002
Synchronized cycles of bacterial lysis for in vivo delivery
Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., et al. (2016) · Nature · doi:10.1038/nature18930 · Cited by 784
Refinement and standardization of synthetic biological parts and devices
Canton, B., Labno, A., & Endy, D. (2008) · Nature Biotechnology · doi:10.1038/nbt1413 · Cited by 753
The gastrointestinal tract. The “undrained abscess” of multiple organ failure
Marshall, J. C., Christou, N. V., & Meakins, J. L. (1993) · Annals of Surgery · doi:10.1097/00000658-199308000-00001 · Cited by 707
de Jonge, E., Schultz, M. J., Spanjaard, L., Bossuyt, P. M., Vroom, M. B., Dankert, J., & Kesecioglu, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14409-1 · Cited by 587
Cited by
Items 301–400 of 481
Mehboudi, N., Rahimi, H. R., Bakhtiari, H. A., Alimardani, M., & Jalili, A. (2023) · Letters in Applied Microbiology · doi:10.1093/lambio/ovad111 · Cited by 9
Microbial Resistance to Antibiotics
Premlatha, M. (2019) · Springer eBooks · doi:10.1007/978-981-13-8503-2_4 · Cited by 10
Fundamental Building Blocks of Whole-Cell Biosensor Design
Wen, K. Y., Rutter, J. W., Barnes, C. P., & Dekker, L. (2019) · Springer eBooks · doi:10.1007/978-3-319-47405-2_181-1 · Cited by 8
Holistic Fitness: Microbiomes are Part of the Holobiont’s Fitness
ROSENBERG, E. B. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-65317-0_4 · Cited by 7
Probiotics, Microbiome and the Concept of Cross-Feeding
Torres-Miranda, A., Vega, M. A., & Garrido, D. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00055-3 · Cited by 8
Quantitative and synthetic biology approaches to combat bacterial pathogens
Wu, F., Bethke, J. H., Wang, M., & You, L. (2017) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2017.10.007 · Cited by 7
Multiplexed biosensors for precision bacteria tropism in vivoPreprint
Chien, T., Harimoto, T., Kepecs, B., Gray, K., Coker, C., Pu, K., Azad, T., & Danino, T. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/851311 · Cited by 7
“Since genetic programming of bacteria enables them to sense and respond to physiological conditions in situ, this approach is poised to change existing paradigms for diagnosing and treating diseases such as inflammation (12, 13), infection (14, 15), and cancer (16-18).”
BackgroundResearch and application of intelligent diagnosis and treatment engineering bacteria
Zhao, N., Chen, J., Shi, J., Gao, Y., Li, L., & Dong, L. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1524376 · Cited by 7
Engineering advanced bacterial therapy for tumor and inflammatory diseases
Chen, Y., & Han, Q. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125585 · Cited by 6
BioFuse: A programmable timer switch of gene expression
Huang, C., Zhao, J., Tan, Z., Dai, S., Wang, B., Xie, Z., Zhang, F., Zhou, Y., Yu, N., Cai, C., et al. (2025) · Science Advances · doi:10.1126/sciadv.adv7892 · Cited by 8
Singh, I., Abdulqadir, R. F., Verma, I. K., Awasthi, Y., Ratn, A., Sharma, J., Rawat, M., Dhakad, M. S., Dalal, J., Gupta, Y., et al. (2025) · Food Frontiers · doi:10.1002/fft2.70168 · Cited by 7
Engineering smart bacteria for the next generation
Qiao, L., Wang, Z., Tang, S., Tian, J., Ye, H., & Cai, F. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102681 · Cited by 12
Multilayered safety framework for living diagnostics in the colon
Mecacci, S., Torregrosa-Barragán, L., Asin‐Garcia, E., & Smith, R. W. (2023) · Frontiers in Systems Biology · doi:10.3389/fsysb.2023.1240040 · Cited by 10
PROT3EcT, engineered Escherichia coli for the targeted delivery of therapeutics
González-Prieto, C., Lynch, J. P., & Lesser, C. F. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.07.007 · Cited by 6
Ungor, I., & Apidianakis, Y. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0155 · Cited by 6
Design and in situ biosynthesis of precision therapies against gastrointestinal pathogens
Durmusoglu, D., Catella, C. M., Purnell, E. F., Menegatti, S., & Crook, N. (2021) · Current Opinion in Physiology · doi:10.1016/j.cophys.2021.06.007 · Cited by 5
Yi, Z., Xiao, X., Zou, L., Cen, C., Shentu, X., Yu, X., & Wang, W. (2026) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuag041 · Cited by 7
“…solutions have been proposed, including cell-penetrating peptides to enhance membrane translocation, nanoparticle or liposomal carriers to improve stability, and exploitation of bacterial nutrient uptake systems or transport pathways for targeted entry (Czaplewski et al. 2016 , Hwang et al. 2017 ).”
Dong, M.-M., Li, Y., Xu, M., Ding, Y.-X., Song, L., Xiong, J., Wei, D., Xiong, L., & Wang, F. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114188 · Cited by 6
Quorum sensing componentry opens new lines of communication
Wang, S., Payne, G. F., & Bentley, W. E. (2022) · The EMBO Journal · doi:10.15252/embj.2022112162 · Cited by 5
“Despite AI-1 signaling networks mainly being used orthogonally, the development of a “smart” Escherichia coli probiotic that hunted down and eradicated AI-1-secreting Pseudomonas aeruginosa from within the mouse gut has been a notable and exciting exception (Hwang et al , 2017).”
Self-citationSynthetic Enzymology and the Fountain of Youth: Repurposing Biology for Longevity
Lim, Y. P., Go, M. K., Raida, M., Inoue, T., Wenk, M. R., Keasling, J. D., Chang, M. W., & Yew, W. S. (2018) · ACS Omega · doi:10.1021/acsomega.8b01620 · Cited by 6
Self-citationUsing Probiotics to Mute Salmonella enteric Serovar Typhimurium: An Opinion
Shi, Y., Li, J., Shen, Y., & Sun, Z. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00558 · Cited by 8
“coli Nissle 1917, similar approaches might be also promising for ST prevention (Hwang et al., 2017; Geldart et al., 2018).”
BackgroundGenome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech
Börner, R. A., Kandasamy, V., Axelsen, A. M., Nielsen, A. T., & Bosma, E. F. (2018) · FEMS Microbiology Letters · doi:10.1093/femsle/fny291s · Cited by 16
“Systems based on quorum-sensing or reciprocal transcriptional repression systems have been used for inducing autolysis in E. coli (Chan et al. 2016; Hwang et al. 2017) and could be adapted to LAB.”
MethodLewis, D. D., Vanella, R., Vo, C., Rose, L. S., Nash, M. A., & Tan, C. (2018) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-018-0552-9 · Cited by 6
Durmusoglu, D., Al’Abri, I. S., Collins, S. P., Beisel, C. L., & Crook, N. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.22.915389 · Cited by 6
Asensio‐Calavia, A., Mañas, C., Cabrera-Fisac, A., Pico-Sánchez, E., Seco, E. M., Kolodziej, S. A., Leventhal, D. S., Lora, J. M., Álvarez, B., & Fernández, L. Á. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.22.590337 · Cited by 5
Antibiotic Alternative Strategies Against Aeromonas hydrophila Infections: New Trends and Advances
Li, S., Dong, J., Zhou, S., Cheng, B., & Ai, X. (2025) · Reviews in Aquaculture · doi:10.1111/raq.70117 · Cited by 6
Wen, C., Zhang, H. S., Guo, Q., Duan, Y., Chen, S., Han, M., Wang, L., Huang, L., Deng, Y., Li, F., et al. (2026) · iMetaOmics. · doi:10.1002/imo2.70094 · Cited by 5
Ding, S., Yang, B., Li, X., Wang, Y., Huang, C., Dong, W., & Xie, W. (2026) · Advanced Science · doi:10.1002/advs.202520434 · Cited by 8
Özçelik, C. E., Tunç, N., Şen, S., & Şeker, U. Ö. Ş. (2026) · Chemistry - A European Journal · doi:10.1002/chem.202503523 · Cited by 4
Hutchinson, N. T., Pang, Z., Chimezie, C. I., Hamp, B., Haley, A. E., & Li, J. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115160 · Cited by 4
Engineering commensal microbes for host health
Brown, E. A., Brevi, A., Zong, D. M., & Zarrinpar, A. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.05.025 · Cited by 4
Microbiome and metabolism: Advancements in microbiome engineering
Mavros, C. F., & Ronda, C. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100404 · Cited by 4
Probiotic‐Based Mineralized Living Materials to Produce Antimicrobial Yogurts
Ramírez‐Rodríguez, G. B., Sabio, L., Cerezo‐Collado, L., Garcés, V., Dominguez-Vera, J. M., & Delgado‐López, J. M. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402793 · Cited by 4
Liu, Y., Cheng, Y., Thompson, J. C., Zhou, Z., Vivas, E. I., Warren, M. F., DuClos, J. M., Anantharaman, K., Rey, F. E., & Venturelli, O. S. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101292 · Cited by 10
Genetically Engineered Probiotics
Hag, S., & Poondla, N. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_14 · Cited by 6
Repurposing E. coli by Engineering Quorum Sensing and Redox Genetic Circuits
Wang, S., Payne, G. F., & Bentley, W. E. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81245 · Cited by 4
Self-citationGut microbes as a therapeutic armory
Bhardwaj, N., & Geva‐Zatorsky, N. (2018) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2019.08.007 · Cited by 4
Application of Bacterial Whole-Cell Biosensors in Health
Song, Y., Rampley, C. P. N., Chen, X., Du, F., Thompson, I. P., & Huang, W. E. (2019) · Springer eBooks · doi:10.1007/978-3-319-47405-2_136-1 · Cited by 4
Transcription Factor‐Based Biosensors and Their Application in Microbiome Engineering
Kim, S. K., Woo, S. G., Kim, T. H., Park, S. H., Lee, J. J., Park, A.-H., Oh, S. H., Bak, S. K., Lee, S., & Lee, D. (2022) · Wiley eBooks · doi:10.1002/9783527825462.ch10 · Cited by 5
A Synthetic Protein Secretion System for Living Bacterial TherapeuticsPreprint
Ahan, R. E., Özçelik, C. E., Çağıl, İ. N., & Şeker, U. Ö. Ş. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.14.544856 · Cited by 5
Ahn, S. H., Karlsson, A. J., Bentley, W. E., & Raghavan, S. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277132 · Cited by 3
Self-citationMa, T., Gan, G., Cheng, J., Shen, Z., Zhang, G., Liu, S., & Hu, J. (2025) · Angewandte Chemie · doi:10.1002/ange.202502588 · Cited by 23
Engineering live bacterial therapeutics to treat human diseases
Hwang, I. Y. (2023) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2023.100492 · Cited by 4
Self-citationAssessing electrogenetic activation via a network model of biological signal propagation
Chun, K., VanArsdale, E. S., May, E. E., Payne, G. F., & Bentley, W. E. (2024) · Frontiers in Systems Biology · doi:10.3389/fsysb.2024.1291293 · Cited by 5
Self-citationGaever, F. V., Vandecruys, P., Driege, Y., Kim, S. W., Thevelein, J. M., Beyaert, R., & Staal, J. (2025) · Metabolic Engineering Communications · doi:10.1016/j.mec.2025.e00263 · Cited by 5
“Engineered probiotics have traditionally been bacterial, with Escherichia coli Nissle 1917 modified to eliminate pathogens like Pseudomonas aeruginosa (Hwang et al., 2017) or to treat conditions such as hyper-ammonemia (Kurtz et al., 2019) and cancer (Ho et al., 2018).”
Probiotics and Prebiotics: Techniques Used and Its Relevance
Khangwal, I., Yadav, M., Mandeep, & Shukla, P. (2020) · Springer eBooks · doi:10.1007/978-981-15-6895-4_10 · Cited by 5
Recent Advances in Genetic Engineering Tools for Metabolic Engineering
Naidoo, J., Fok, E. T., Grobler, L., Molaoa, R. R., Nxumalo, Z., Selvamani, P., Latha, S., & Raj, D. B. T. G. (2020) · Springer eBooks · doi:10.1007/978-981-15-2604-6_6 · Cited by 3
Chen, S., He, X., Qin, Z., Li, G., Wang, W., Nai, Z., Tian, Y., Liu, D., & Jiang, X. (2023) · Microorganisms · doi:10.3390/microorganisms11102371 · Cited by 3
“The programmable autolysis and killing of specific pathogens have been genetically engineered in the bacterial reprogramming of E. coli [25,26] and could be adapted to LAB.”
BackgroundDong, S., & Zhai, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822548-6.00033-9 · Cited by 3
Chen, S., Li, G., Bao, J., Qin, Z., He, X., Wang, W., Nai, Z., Xia, J., Liu, D., & Jiang, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2470002/v1 · Cited by 3
Linear scaling reveals low-dimensional structure in observable microbial dynamics
Zhou, Z., Chen, X., Baig, Y., Wang, W. K., Şimşek, E., Hamrick, G. S., Holmes, Z. A., Du, Z., Karig, D., & You, L. (2026) · Proceedings of the National Academy of Sciences · doi:10.1101/2025.06.13.659614 · Cited by 3
Fields, B. D., Pascal, D. G., Rando, O. K., Huddleston, M., Ingram, K., Hopton, R., Grogg, M. W., Nelson, M., & Voigt, C. A. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00690 · Cited by 2
Reprogrammed SimCells for antimicrobial therapy
Dong, Y. J., Ji, X., Dong, T., Wang, Y., Bakkeren, E., Foster, K. R., & Huang, W. E. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2517118123 · Cited by 2
Engineered microbes for cancer immunotherapy
Brennan, A. M., Sokolovska, A., Li, N., & Isabella, V. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90949-5.00002-4 · Cited by 2
MvaT negatively regulates pyocin S5 expression in Pseudomonas aeruginosa
Liu, R., Sotto, R. D., & Ling, H. (2022) · Biotechnology Notes · doi:10.1016/j.biotno.2022.11.004 · Cited by 2
“21 McCaughey et al. have shown that pyocin S5 at a low concentration shows strong efficacy in a murine model of P. aeruginosa lung infection.”
The Application Potential of Synthetic Biology in Microbial Communication
Wang, Y., & Zhou, J. (2023) · Current Clinical Microbiology Reports · doi:10.1007/s40588-023-00205-6 · Cited by 2
“Hwang et al. [78] developed a synthetic genetic system encoding an anti-biofilm enzyme, which enables E. coli to synthesize pyocyanin to lyse P. aeruginosa and inhibit the formation of biofilm, thereby preventing intestinal infection.”
BackgroundProbiotics in Action: Enhancing Immunity and Combatting Diseases for Optimal Health
Singh, A., Mazumder, A., Das, S., Tyagi, P. K., & Chaitanya, M. (2024) · Journal of Natural Remedies · doi:10.18311/jnr/2024/35894 · Cited by 2
Metagenomics-guided reengineering of the gut microbiome
Dhotre, D. P., & Karmarkar, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91631-8.00011-1 · Cited by 2
Synthetic gene circuits for higher-order information processing
Sarkar, K., & Bagh, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824469-2.00003-8 · Cited by 2
Kim, T. H., Ju, K., Kim, S. K., Woo, S., Lee, J., Lee, C., Rha, E., Shin, J., Kwon, K. K., Lee, H., et al. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00649 · Cited by 3
Swaby, A. M., & Agellon, L. B. (2022) · Recent Progress in Nutrition · doi:10.21926/rpn.2202014 · Cited by 2
Probiotic Associated Therapeutic Curli Hybrids (PATCH)Preprint
Praveschotinunt, P., Duraj‐Thatte, A., Gelfat, I., Bahl, F., Chou, D. B., & Joshi, N. S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/464966 · Cited by 2
Remodeling gut microbiota by Streptococcus thermophilus 19 attenuates inflammation in septic micePreprint
Han, F., Zhang, Y., Yang, X., Fang, Z., Han, S., Li, X., Cai, W., Xiao, D., Liu, J., Zhang, W., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/543967 · Cited by 2
“Furthermore, probiotics can alleviate inflammation associated with some human 74 diseases by promoting changes in the gut microbiota composition (11, 12).”
BackgroundEngineered E. coli for the targeted deposition of therapeutic payloads to sites of diseasePreprint
Lynch, J. P., González-Prieto, C., Reeves, A. Z., Powale, U., Godbole, N. P., Tremblay, J. M., Schmidt, F. I., Ploegh, H. L., Glickman, J. N., Leong, J. M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1233122/v1 · Cited by 2
Repurposing Microbes for Therapeutic Applications in Humans
Kim, K., Choe, D., Kang, M., Sung, B. H., Kim, H., Lee, S., Lee, D., & Cho, B. (2022) · Wiley eBooks · doi:10.1002/9783527825462.ch3 · Cited by 2
Big Data to Expand the Antimicrobial Therapeutic Arsenal: De Novo Discovery and Drug Repurposing
Tarín-Pelló, A., Suay‐García, B., Falcó, A., & Pérez‐Gracia, M. T. (2023) · Advances in information quality and management · doi:10.4018/978-1-6684-7366-5.ch027 · Cited by 1
Role of prebiotics, probiotics, and synbiotics in the management of colonic disorders
Razali, F. N., Teoh, W. Y., Ramli, M. Z., Loo, C., & Gnanaraj, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14044-0.00002-8 · Cited by 1
Building a Better Microbiome: Advances in Microbiome Engineering for Human Health
Munir, S., Aslam, S., Imran, M., Ashfaq, U. A., Ejaz, H., Taqveem, A., & Khurshid, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_20 · Cited by 1
Three-Dimensional Imaging of Native Microbiota in Intact Colon
Du, Y., Zhou, Y., Lin, H., Yang, C. J., & Wang, W. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c06059 · Cited by 1
Garrote-Sánchez, E., Moyá, A., & Gil, R. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1527084 · Cited by 1
Ji, W., Yang, D., Zhang, W., Wang, Y., Hao, Z., Guo, K., Sun, X., Wang, S., Yang, S., Ma, J., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10664-6 · Cited by 1
Larsson, E. M., Wang, O. Y., & Murray, R. M. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.5c00414 · Cited by 1
Yang, Y., Yan, W., Zhao, Y., Gao, T., Yang, Y., Cao, L., Tao, R., Liu, N., Yang, Y., Liu, Y., et al. (2025) · Biology Direct · doi:10.1186/s13062-025-00689-w · Cited by 1
“Microscopy of biofilms was performed as previously described [24].”
Mazzolini, R., Garrido, V., Gómez, A.-C., Collantes, M., Grilló, M. J., Piñero‐Lambea, C., Gibert, I., Yero, D., & Lluch‐Senar, M. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00835-2 · Cited by 1
Cytrynbaum, E. G., & McClean, M. N. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115740 · Cited by 1
Associate toxin–antitoxin with CRISPR-Cas to harness (ATTACH) engineered microbes
Zhao, H., Zhou, T., Zhang, M., Wang, C., Wang, R., Shu, X., Cheng, F., Xue, Q., Liu, C., Xu, J., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag213 · Cited by 2
Engineering quorum sensing: new directions for antimicrobial therapy
Urbauer, E., Gräwe, A., Chamas, A., & Papenfort, K. (2026) · Trends in Microbiology · doi:10.1016/j.tim.2026.05.006 · Cited by 1
Engineering Bacteria for Medicine: Delivery, Diagnosis, and Therapy
Xia, S., Fu, G., Ding, X., Yang, W., Bai, R., Cai, Y., Zhang, J. X., Wei, Y., Han, C., Gao, Y., et al. (2026) · iMetaMed · doi:10.1002/imm3.70046 · Cited by 3
Fundamental Building Blocks of Whole-Cell Biosensor Design
Wen, K. Y., Rutter, J. W., Barnes, C. P., & Dekker, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-23217-7_181 · Cited by 3
Diagnostic and Therapeutic Biotechnology
Raina, A., Villingiri, V., Jehan, S., & Qadir, S. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-98554-7_10 · Cited by 3
Challenges of Breast Cancer Treatment through Microbial Therapeutic Delivery
Khan, M. S. S., Haque, S., & Fakruddin, M. (2023) · Microbial Bioactives · doi:10.25163/microbioactives.619347 · Cited by 1
Human Microbiome as Drug Delivery System
Vyas, T., Dhoble, A. S., Pandey, M., & Singhvi, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00006-1 · Cited by 1
He, L., Tang, W., Huang, L., Zhou, W., Huang, S., Zou, L., Yuan, L., Men, D., Chen, S., & Hu, Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.17.488604 · Cited by 1
Bhowmik, D., Heer, K., Kaur, M., Raychaudhuri, S., & Paul, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.10.495602 · Cited by 1
“In another case, genetically engineered EcN can effectively sense and eliminate Pseudomonas aeruginosa in animal models (6).”
BackgroundEngineered E. coli for the Targeted Deposition of Therapeutic Payloads to Sites of DiseasePreprint
Lynch, J. P., González-Prieto, C., Reeves, A. Z., Powale, U., Godbole, N. P., Tremblay, J. M., Schmidt, F. I., Ploegh, H. L., Glickman, J. N., Leong, J. M., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4133893 · Cited by 2
Liu, Y., Cheng, Y., Thompson, J. C., Zhou, Z., Vivas, E. I., Warren, M. F., Rey, F. E., Anantharaman, K., & Venturelli, O. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.10.523442 · Cited by 1
Zhang, X., Feng, Z., Li, L., Yang, H., Dai, P., Yang, C., Sun, D., Li, H., Wang, H., Xue, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.24.595785 · Cited by 1
Nguyen, N. T., Wang, M., Li, L., & Chan, C. T. Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.16.628630 · Cited by 1
Implantable Living Materials Autonomously Deliver Therapeutics from Contained Engineered BacteriaPreprint
Harimoto, T., Quevedo, F., Zillig, J., Schreiber, S., Wu, Y. X., Ahn, C. H., To, T., Thakur, R., Tatara, A. M., Kang, S. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.09.681377 · Cited by 1
Bernard, L. (2020) · theses.fr (ABES) · doi:10.70675/589a776dz18d9z4813z9d6fzd73632aa4df7 · Cited by 1
Engineering Probiotic Bacteria for Use as Antibiotic Alternatives
Forkus, B. (2018) · University of Minnesota Digital Conservancy (University of Minnesota)
Synthetic Gene Circuits in Intestinal Bacteria: Biosensors and Pulse Counters
Naydich, A. D. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Microbiote et syndrome de l’intestin irritable : que faut-il savoir ? Perspectives thérapeutiques
Bazin, T. (2020) · Côlon & Rectum · doi:10.3166/cer-2020-0141
Cheng, M., Cheng, Z., Yu, Y., Liu, W., Li, R., Guo, Z., Qin, J., Zeng, Z., Di, L., Mo, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.15.297564
Expanding the bio-capabilities of Lactococcus lactis through efficient genome modification
Rothstein, S. M. (2020) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-20210114-128
Functional engineering of microneedles for transdermal drug delivery
Chew, S. W. T. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/148914
Chassis engineering of E. coli Nissle 1917 for development of live biotherapeutics
Zainuddin, H. S. B. (2021) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-20210609-205
Ritter, S. C. (2019) · University of Minnesota Digital Conservancy (University of Minnesota)
In vitro reconstituted quorum sensing pathways enable rapid evaluation of quorum sensing inhibitorsPreprint
Yu, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.29.466404
“aeruginosa, there are cell-free biosensors [32] and engineered “sense-and-kill” bacteria [33,34] based on its QS pathways reported, using”
BackgroundXu, M., Cheng, K., Zeng, Y., Zhou, J., & Chen, G. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0167 · Cited by 1
Metadata
- Authors
- Hwang, I. Y., Koh, E., Wong, A., March, J. C., Bentley, W. E., Lee, Y. S., & Chang, M. W.
- Affiliations
- National University of Singapore (SG)
- Cornell University (US)
- University of Maryland, College Park (US)
- Corresponding author
- Chang, Matthew Wook
- ORCID
- Venue
- Nature Communications
- Published
- 2017-04-11
- Volume
- 8
- Issue
- 1
- Pages
- 15028-15028
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5394271
- OpenAlex
- W2605968366
- Cited by
- 472
- References
- 50
- Citations by year
- 2026: 44 · 2025: 53 · 2024: 51 · 2023: 55 · 2022: 68 · 2021: 44 · 2020: 54 · 2019: 53 · 2018: 41 · 2017: 9
- FWCI
- 31.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National University of Singapore (DPRT/943/09/14)
- National University Health System
- Defense Threat Reduction Agency (HDTRA1‐13‐0037, HDTRA1, DPRT/943/09/14)
- U.S. Air Force
- Medical Research Council
- National Medical Research Council (CBRG11nov109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- engineered probiotics, Escherichia coli, Pseudomonas aeruginosa, intestinal infection, Escherichia coli Nissle 1917, prophylaxis, therapeutic activities, Caenorhabditis elegans, mouse model
- MeSH terms
- Microorganisms, Genetically-Modified, Animals, Disease Models, Animal, Escherichia coli, Female, Gastroenteritis, Genetic Engineering, Mice, Inbred ICR, Pseudomonas aeruginosa, Pseudomonas Infections, Virulence, Caenorhabditis elegans, Probiotics, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.